Načítá se...
Human immune globulin 10% with recombinant human hyaluronidase in multifocal motor neuropathy
OBJECTIVE: The primary aim was to determine the safety of treatment with human immune globulin 10% with recombinant human hyaluronidase (fSCIg) compared to intravenous immunoglobulin (IVIg) in a prospective open-label study in patients with multifocal motor neuropathy (MMN). METHODS: Our study consi...
Uloženo v:
| Vydáno v: | J Neurol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6803588/ https://ncbi.nlm.nih.gov/pubmed/31325017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-019-09475-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|